430 related articles for article (PubMed ID: 35320687)
21. Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic.
Sasso JM; Tenchov R; Wang D; Johnson LS; Wang X; Zhou QA
Biochemistry; 2023 Feb; 62(3):601-623. PubMed ID: 35856839
[TBL] [Abstract][Full Text] [Related]
22. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase.
Smith BE; Wang SL; Jaime-Figueroa S; Harbin A; Wang J; Hamman BD; Crews CM
Nat Commun; 2019 Jan; 10(1):131. PubMed ID: 30631068
[TBL] [Abstract][Full Text] [Related]
23. Haven't got a glue: Protein surface variation for the design of molecular glue degraders.
Kozicka Z; Thomä NH
Cell Chem Biol; 2021 Jul; 28(7):1032-1047. PubMed ID: 33930325
[TBL] [Abstract][Full Text] [Related]
24. Clinical Translation of Targeted Protein Degraders.
Kong NR; Jones LH
Clin Pharmacol Ther; 2023 Sep; 114(3):558-568. PubMed ID: 37399310
[TBL] [Abstract][Full Text] [Related]
25. Crbn-based molecular Glues: Breakthroughs and perspectives.
An J; Zhang X
Bioorg Med Chem; 2024 Apr; 104():117683. PubMed ID: 38552596
[TBL] [Abstract][Full Text] [Related]
26. The importance of cellular degradation kinetics for understanding mechanisms in targeted protein degradation.
Riching KM; Caine EA; Urh M; Daniels DL
Chem Soc Rev; 2022 Jul; 51(14):6210-6221. PubMed ID: 35792307
[TBL] [Abstract][Full Text] [Related]
27. Targeted protein degradation and the enzymology of degraders.
Fisher SL; Phillips AJ
Curr Opin Chem Biol; 2018 Jun; 44():47-55. PubMed ID: 29885948
[TBL] [Abstract][Full Text] [Related]
28. New Frontiers in the Discovery and Development of PROTACs.
Barghout SH
Anticancer Agents Med Chem; 2022 Aug; 22(15):2656-2661. PubMed ID: 35418290
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic and Structural Features of PROTAC Ternary Complexes.
Casement R; Bond A; Craigon C; Ciulli A
Methods Mol Biol; 2021; 2365():79-113. PubMed ID: 34432240
[TBL] [Abstract][Full Text] [Related]
30. HECT-Type E3 Ubiquitin Ligases in Cancer.
Bernassola F; Chillemi G; Melino G
Trends Biochem Sci; 2019 Dec; 44(12):1057-1075. PubMed ID: 31610939
[TBL] [Abstract][Full Text] [Related]
31. Identifying E3 Ligase Substrates With Quantitative Degradation Proteomics.
Jordan VN; Ordureau A; An H
Chembiochem; 2023 Aug; 24(16):e202300108. PubMed ID: 37166757
[TBL] [Abstract][Full Text] [Related]
32. Receptor Elimination by E3 Ubiquitin Ligase Recruitment (REULR): A Targeted Protein Degradation Toolbox.
Siepe DH; Picton LK; Garcia KC
ACS Synth Biol; 2023 Apr; 12(4):1081-1093. PubMed ID: 37011906
[TBL] [Abstract][Full Text] [Related]
33. An E3 ligase guide to the galaxy of small-molecule-induced protein degradation.
Jevtić P; Haakonsen DL; Rapé M
Cell Chem Biol; 2021 Jul; 28(7):1000-1013. PubMed ID: 33891901
[TBL] [Abstract][Full Text] [Related]
34. Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
Bondeson DP; Smith BE; Burslem GM; Buhimschi AD; Hines J; Jaime-Figueroa S; Wang J; Hamman BD; Ishchenko A; Crews CM
Cell Chem Biol; 2018 Jan; 25(1):78-87.e5. PubMed ID: 29129718
[TBL] [Abstract][Full Text] [Related]
35. High throughput E3 ligase degron binding assays for novel PROTAC ligand discovery.
Guenette RG; Potts PR
Methods Enzymol; 2023; 681():23-39. PubMed ID: 36764759
[TBL] [Abstract][Full Text] [Related]
36. Systematic approaches to identify E3 ligase substrates.
Iconomou M; Saunders DN
Biochem J; 2016 Nov; 473(22):4083-4101. PubMed ID: 27834739
[TBL] [Abstract][Full Text] [Related]
37. Targeted protein degradation: Emerging concepts and protein state-specific targeting principles.
Tao AJ; Gadbois GE; Buczynski SA; Ferguson FM
Curr Opin Chem Biol; 2022 Apr; 67():102114. PubMed ID: 35042023
[TBL] [Abstract][Full Text] [Related]
38. Perspectives on the development of first-in-class protein degraders.
Rambacher KM; Calabrese MF; Yamaguchi M
Future Med Chem; 2021 Jul; 13(14):1203-1226. PubMed ID: 34015962
[TBL] [Abstract][Full Text] [Related]
39. Exploring the Rampant Expansion of Ubiquitin Proteomics.
Rose A; Mayor T
Methods Mol Biol; 2018; 1844():345-362. PubMed ID: 30242720
[TBL] [Abstract][Full Text] [Related]
40. Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency.
Chaudhry C
J Med Chem; 2023 May; 66(9):6239-6250. PubMed ID: 37102218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]